Navigation Links
Novel Bonding Chemistry Imparts Enhanced Polar Selectivity to TSK-GEL ODS-100V Reversed Phase Columns


Introduction
While full coverage C18 phases have been responsible for the growth of HPLC as a reliable high efficiency technique, it has become apparent in recent years that such column types are not suited for reliable analysis of highly polar compounds under low organic or aqueous mobile phase conditions. It was shown that by incorporating a polar group in the alkyl bonded phase reagent extra retention could be obtained for polar solutes while maintaining the operating characteristics of traditional reversed phase columns. Adding polarity to the bonded alkyl phase also overcame 'bonded phase collapse', the steady decline of retention times under (near) aqueous mobile phase conditions. In this note we report on an alternative method to obtain enhanced retention of polar solutes by creating a low density bonded phase that is fully accessible to water molecules.


Results
TSK-GEL ODS-100V columns contain high purity five micron silica particles with 100 angstrom pores and 450m2/g surface area, which are functionalized by an incomplete reaction with a difunctional octadecylsilane reagent (see Figure 1 ). The low density C18 monolayer is then endcapped with two difunctional dialkylsilane reagents to improve the peak shape of basic compounds, while maintaining stable analysis times in low organic or aqueous mobile phases.


To demonstrate the absence of accessible silanol groups, Figure 2 compares retention and peak shape for two tricyclic antidepressant drugs on four commercial water-wettable columns.


The same commercial columns were also evaluated wi th organic acids under low pH conditions in 2% acetonitrile, as is shown in Figure 3 .



Conclusion
The ability to provide symmetrical peak shapes for basic as well as acidic compounds make TSKgel ODS-100V the column of choice for method development and quantitative analysis of small molecular weight compounds.


Ordering Information


More Infomation
TSKgel ODS-100V



'"/>

Source:


Page: All 1 2

Related biology technology :

1. Novel PCR Enhancing Factor Improves Performance of Pfu DNA Polymerase
2. High-Fidelity PCR with a Novel Polymerase Mixture
3. Challenge the Performance of Your Hot-Start PCRs with FastStart Taq DNA Polymerase and the Novel FastStart High Fidelity PCR System
4. Combine High Yield, Great Accuracy and the Prevention of Carry-over Contamination by Using the Novel Expand High FidelityPLUS PCR System
5. Novel MicroRNA Array Technology for Sensitive miRNA Profiling
6. A Novel Process for Gene Expression Profiling of Rat and Mouse Tissues from Formalin-Fixed Paraffin-Embedded Sections Using Microarrays
7. Use of Novel FlashPlate Technology to Measure cAMP Accumulation in Chinese Hamster Ovary Cells Expressing Human -2 Adrenoreceptors
8. ESR1 Gene Expression in Oncology and Metabolic Diseases Using the ASCENTATM System Target Validation and Identification of Novel Disease Indications
9. Unique Surface Treatment of Novel TSK-GEL ODS Columns Provide Separation of Aqueous and Fat Soluble Vitamins
10. Enhanced PCR Cloning System
11. Enhanced Amplification of Long Targets with PfuTurbo DNA Polymerase
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)...  Liquid Biotech USA , ... Sponsored Research Agreement with The University of Pennsylvania ... cancer patients.  The funding will be used to ... clinical outcomes in cancer patients undergoing a variety ... employed to support the design of a therapeutic, ...
(Date:6/24/2016)... , June 24, 2016 Epic ... sensitively detects cancers susceptible to PARP inhibitors by ... tumor cells (CTCs). The new test has already ... therapeutics in multiple cancer types. Over ... DNA damage response pathways, including PARP, ATM, ATR, ...
(Date:6/23/2016)... WA (PRWEB) , ... June 23, 2016 , ... ... announces the release of its second eBook, “Clinical Trials Patient Recruitment and Retention ... recruitment and retention in this eBook by providing practical tips, tools, and strategies ...
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
Breaking Biology Technology:
(Date:5/20/2016)...  VoiceIt is excited to announce its new ... By working together, VoiceIt and VoicePass will offer ... take slightly different approaches to voice biometrics, collaboration ... usability. Both ... "This marketing and technology partnership allows ...
(Date:5/3/2016)...  Neurotechnology, a provider of high-precision biometric identification ... Identification System (ABIS) , a complete system for ... can process multiple complex biometric transactions with high ... face or iris biometrics. It leverages the core ... MegaMatcher Accelerator , which have been used in ...
(Date:4/26/2016)... , April 27, 2016 ... "Global Multi-modal Biometrics Market 2016-2020"  report to their ... , The analysts forecast the global ... of 15.49% during the period 2016-2020.  ... of sectors such as the healthcare, BFSI, transportation, ...
Breaking Biology News(10 mins):